Tasuku Honjo | |
---|---|
本庶 佑 | |
Born | |
Nationality | Japanese[1] |
Education | Kyoto University (BS, MD, PhD) |
Known for | |
Awards |
|
Scientific career | |
Fields | Molecular Immunology |
Institutions | Kyoto University |
Doctoral advisor | |
Notable students | Shizuo Akira |
Tasuku Honjo (本庶 佑, Honjo Tasuku, born January 27, 1942)[2] is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1).[3] He is also known for his molecular identification of cytokines: IL-4 and IL-5,[4] as well as the discovery of activation-induced cytidine deaminase (AID) that is essential for class switch recombination and somatic hypermutation.[5]
He was elected as a foreign associate of the National Academy of Sciences of the United States (2001), as a member of German Academy of Natural Scientists Leopoldina (2003), and also as a member of the Japan Academy (2005).
In 2018, he was awarded the Nobel Prize in Physiology or Medicine along with James P. Allison.[6] He and Allison together had won the 2014 Tang Prize in Biopharmaceutical Science for the same achievement.[7]